Articles
| Open Access |
https://doi.org/10.55640/
RADIOLOGIC DIAGNOSIS OF BONE CHANGES IN MULTIPLE MYELOMA
Vahidov Feruz,Makhmonov Lutfullo,Janiyev Khoshim,Madasheva Anajan , Head of the X-ray and radiology department, Samarkand Regional multi-network medical center,PhD, chief physician of Samarkand Regional multi-network medical center, Head of the Department of Hematology of Samarkand State Medical University,Multislice CT (MSCT) radiologist of the Samarkand Regional multi-network medical center,PhD, Senior lecturer of the department of hematology Samarkand State Medical UniversityAbstract
Multiple myeloma (MM) is a clonal plasma cell neoplasm frequently accompanied by destructive bone disease, which constitutes a major source of morbidity through pain, pathologic fractures, hypercalcemia, and spinal cord compression. Bone involvement results from uncoupled remodeling characterized by heightened osteoclast activity and suppressed osteoblast function, producing purely osteolytic lesions without sclerotic reaction. This cross-sectional study assessed the spectrum of radiologic bone changes in 68 patients with newly diagnosed or suspected MM at a tertiary medical center in Tashkent, Uzbekistan. Conventional skeletal survey identified bone abnormalities in 72.1% of cases, with classic “punched-out” lytic lesions most prevalent in the skull (55.9%), vertebrae (50.0%), and pelvis (41.2%). Whole-body low-dose CT (WBLDCT), performed in a subset of 42 patients, detected additional osteolytic lesions in 21.4% of those with negative or equivocal skeletal surveys. MRI demonstrated focal or diffuse marrow infiltration patterns in 80% and 40% of examined cases, respectively, often before overt cortical destruction. A significant positive correlation was observed between the number of lytic lesions and Durie-Salmon stage (r = 0.54, p < 0.01), as well as negative correlations with hemoglobin levels (r = −0.58, p < 0.01) and positive correlations with β2-microglobulin (r = 0.51, p < 0.01). These results emphasize the limitations of traditional skeletal survey and the superior sensitivity of modern whole-body imaging techniques (WBLDCT and MRI) for accurate detection and staging of bone disease in MM. Early radiologic diagnosis using advanced modalities is critical for risk stratification, prevention of skeletal-related events, and optimization of therapeutic strategies, particularly in resource-variable settings.
Keywords
Multiple myeloma, osteolytic bone lesions, punched-out lesions, skeletal survey, whole-body low-dose CT, magnetic resonance imaging, bone marrow infiltration, myeloma bone disease
References
Baffour, F. I., et al. (2020). Role of imaging in multiple myeloma. American Journal of Hematology, 95(11), 1375–1387. https://doi.org/10.1002/ajh.25846
Hansford, B. G., et al. (2018). Advanced imaging of multiple myeloma bone disease. Frontiers in Endocrinology, 9, Article 436. https://doi.org/10.3389/fendo.2018.00436
Healy, C. F., et al. (2011). Multiple myeloma: A review of imaging features and radiological techniques. Bone Marrow Research, 2011, Article 583439. https://doi.org/10.1155/2011/583439
Hillengass, J., et al. (2017). Whole-body computed tomography versus conventional skeletal survey in patients with multiple myeloma. Blood Cancer Journal, 7(12), Article e599. https://doi.org/10.1038/bcj.2017.78
Messiou, C., et al. (2019). Myeloma Response Assessment and Diagnosis System (MY-RADS): Consensus guidelines. Radiology, 291(1), 5–13. https://doi.org/10.1148/radiol.2019181949
Moulopoulos, L. A., et al. (2018). Consensus recommendations for the optimal use of imaging in multiple myeloma. Blood Cancer Journal, 8(7), Article 67. https://doi.org/10.1038/s41408-018-0124-1
Ormond Filho, A. G., et al. (2019). Whole-body imaging of multiple myeloma: Diagnostic criteria. RadioGraphics, 39(3), 644–664. https://doi.org/10.1148/rg.2019180096
Pierro, A., et al. (2021). Whole-body low-dose multidetector-row CT in multiple myeloma. Life, 11(12), Article 1320. https://doi.org/10.3390/life11121320
Gazkhanovna, M. A., Makhmatovich, A. K., & Utkirovich, D. U. (2022). Clinical efficacy of extracorporeal and intravascular hemocorrection methods in psoriasis. Academicia: An International Multidisciplinary Research Journal, 12(2), 313-318.
Madasheva, A. G., & Abdiev, K. M. (2023). Blood transfusion therapy in patients with vitamin B12 deficiency anemia after resection of 2/3 of the stomach. Science and Education, 4(5), 407-412.
Мадашева, А. Г., & Жураева, М. З. (2019). Биохимические показатели и комплексное лечение больных псориазом с лечебным плазмаферезом. Достижения науки и образования, (10 (51)), 78-82.
Мадашева, А., Бергер, И., Махмудова, А., Абдиев, К., & Амерова, Д. (2025). Лабораторная диагностика. восточная европа. лабораторная диагностика, 14(1), 87-96.
Мадашева, А. Г. (2022). Клинико-неврологические изменения у больных гемофилией с мышечными патологиями. Science and Education, 3(12), 175-181.
Мадашева, А. Г. (2022). Коррекция диффузной алопеции при железодефицитной анемии. Science and Education, 3(12), 231-236.
Мадашева, А. Г., Дадажанов, У. Д., Абдиев, К. М., Маматкулова, Ф. Х., & Махмудова, А. Д. (2019). Динамика электронейромиографических показателей и эффективность электрической стимуляции мышц у больных гемофилией с мышечными атрофиями. Достижения науки и образования, (10 (51)), 26-30.
Мадашева, А. Г., & Жураева, М. З. (2019). Биохимические показатели и комплексное лечение больных псориазом с лечебным плазмаферезом. Достижения науки и образования, (10 (51)), 78-82.
Article Statistics
Downloads
Copyright License

This work is licensed under a Creative Commons Attribution 4.0 International License.